Given that 5-FU/oxaliplatin activates cGAS/STING signaling and elevates PD-L1 expression, we hypothesized that the combination of 5-FU/oxaliplatin and anti-PD-1 treatment would effectively inhibit tumor growth in immune competent mice. The gene discussed is STING1; the disease is neoplasm.